Related Experiment Videos
Substances which modulate leukocyte migration are present in CSF during meningitis
Annals of Neurology
|April 1, 1979
Summary
Cerebrospinal fluid from meningitis patients attracts leukocytes. An unusual case revealed a leukocyte chemotaxis inhibitor in CSF, potentially impairing host defenses against staphylococcal meningitis.
Area of Science:
- Immunology
- Neuroscience
- Infectious Diseases
Background:
- Meningitis involves inflammation of the membranes surrounding the brain and spinal cord.
- Leukocyte migration to the central nervous system is crucial for combating infection.
- Cerebrospinal fluid (CSF) composition can reflect inflammatory and infectious processes.
Purpose of the Study:
- To investigate the effects of cerebrospinal fluid (CSF) from meningitis patients on leukocyte migration in vitro.
- To identify potential chemotactic factors or inhibitors within CSF that influence leukocyte behavior.
- To explore the role of CSF mediators in host defense mechanisms during meningitis.
Main Methods:
- Collected CSF samples from 14 patients with meningitis and 7 control individuals without meningitis.
- Assessed the chemotactic activity of CSF on peripheral blood leukocytes using in vitro migration assays.
- Screened CSF samples for the presence of inhibitors of leukocyte chemotaxis.
Main Results:
- CSF from meningitis patients demonstrated chemotactic activity for peripheral blood leukocytes.
- Control CSF did not exhibit significant chemotactic activity.
- An inhibitor of leukocyte chemotaxis was identified in the CSF of one patient with staphylococcal meningitis, characterized by blunted pleocytosis and poor antibiotic response.
Conclusions:
- Meningitic CSF contains factors that promote leukocyte migration, suggesting a role in the inflammatory response.
- The identified CSF inhibitor may impair leukocyte accumulation, potentially compromising host defense in specific meningitis cases.
- Soluble mediators in CSF can modulate leukocyte accumulation, significantly impacting host defense and clinical outcomes in meningitis.